Export 1 results:
Author Title Type [ Year
Filters: Keyword is Antineoplastic Agents, Immunological [Clear All Filters]
Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial. J Immunother Cancer. 2020;8(2). doi:10.1136/jitc-2020-001561.